User profiles for Soroush Zarehparvar Moghadam

Soroush Zarehparvar Moghadam

Nuclear Medicine Physician, Nuclear Medicine Research Center, Mashhad University of …
Verified email at mums.ac.ir
Cited by 73

Peptide receptor radionuclide therapy in merkel cell carcinoma: a comprehensive review

E Askari, SZ Moghadam, D Wild… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Merkel cell carcinoma is a rare, aggressive skin malignancy, also known as neuroendocrine
carcinoma of the skin, with high rates of recurrence and distant metastasis. In refractory …

68Ga-FAPI-46 PET/CT in a metastatic castration-resistant prostate cancer patient with low PSMA expression

…, H Amini, G Divband, SZ Moghadam - Clinical Nuclear …, 2022 - journals.lww.com
A 70-year-old man with mCRPC (metastatic castration-resistant prostate cancer) was referred
for 68 Ga-PSMA PET/CT for restaging and the possibility of targeted molecular radioligand …

Favorable response after only one cycle of peptide receptor radionuclide therapy with 177Lu-DOTATATE in a patient with metastatic Merkel cell carcinoma

SZ Moghadam, G Divband, S Shakeri… - Clinical Nuclear …, 2019 - journals.lww.com
A 77-year-old man with a history of metastatic Merkel cell carcinoma and debilitating painful
cutaneous lesions was referred to our nuclear medicine department for peptide receptor …

Efficacy, safety and prognostic factors affecting overall survival among metastatic prostate cancer patients undergoing treatment with 177Lu-PSMA-617: a single …

SZ Moghadam, E Askari, G Divband, S Shakeri… - Revista Española de …, 2022 - Elsevier
… Author links open overlay panel Soroush Zarehparvar Moghadam 1 , Emran Askari 1 , …
Please cite this article as: Moghadam SZ, Askari E, Divband G, Shakeri S, Aryana K. Factores …

[HTML][HTML] Sagliker syndrome in a patient with secondary hyperparathyroidism and chronic renal insufficiency: a case report

S Shakeri, SZ Moghadam, R Sadeghi… - Asia Oceania Journal of …, 2018 - ncbi.nlm.nih.gov
Sagliker syndrome is a rare form of renal osteodystrophy resulted from untreated secondary
hyperparathyroidism. It is described by severe skeletal deformities, high level of PTH in …

99mTc-PSMA Left Behind: a Call for Collaboration

SZ Moghadam, E Askari, K Aryana - Nuclear Medicine and Molecular …, 2022 - Springer
Dear editor, We read with great interest the recent case report of Osayande et al.[1] showing
diffuse marrow involvement (ie, superscan) in a patient with metastatic castration-resistant …

[HTML][HTML] Evaluation of 95 cases with Mediastinal tumors

…, S Zarehparvar Moghaddam… - Journal of Cardio …, 2015 - jctm.mums.ac.ir
Introduction:Mediastinum contains different vital structures that are located in the anterior and
middle or posterior compartments. Various types of mediastinal masses or tumors can be …

Benign high-flow priapism with a diffuse and intense 18F-FDG uptake on 18F-FDG PET/CT scanning

Z Nasiri, SZ Moghadam, Z Kiamanesh… - Clinical nuclear …, 2019 - journals.lww.com
We present benign high-flow priapism with intensive 18 F-FDG uptake as an unusual finding
in a case of testicular teratocarcinoma with a history of left orchiectomy and chemotherapy. …

Complete Resolution of Locally Advanced Prostate Cancer After Molecular Endoradiotherapy With 177Lu-PSMA

M Beheshti, R Vali, SZ Moghadam… - Clinical Nuclear …, 2022 - journals.lww.com
A 76-year-old man with castration-resistant prostate cancer underwent 68 Ga–prostate-specific
membrane antigen (PSMA) PET/CT for restaging. A large PSMA-avid tumor with invasion …

Medical Event: Accidental Oral Administration of: 177: Lu-PSMA to a Patient With Hyperthyroidism

SZ Moghadam, A Aghaee, M Esmatinia… - Clinical Nuclear …, 2020 - journals.lww.com
A 74-year-old woman with hyperthyroidism was referred for radioiodine therapy. The patient
was accidentally given 60 mCi of 177 Lu-PSMA orally instead of 131 I. Upon discovery of …